Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1b/2a trial of IT 139

Trial Profile

Phase 1b/2a trial of IT 139

Phase of Trial: Phase I/II

Latest Information Update: 15 Mar 2018

At a glance

  • Drugs IT 139 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 15 Mar 2018 According to an Intezyne media release, the company expects to initiate one or more combination Phase 1/2 studies by early 2019.
    • 07 Apr 2017 New trial record
    • 31 Mar 2017 According to an Intezyne media release, company plans to initiate this trial in early 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top